BiotechTube
Home/Pipeline/Chemophototherapy (CPT)

Chemophototherapy (CPT)

Oncology (Solid Tumors)

Pre-clinicalActive

Key Facts

Indication
Oncology (Solid Tumors)
Phase
Pre-clinical
Status
Active
Company
POP Biotechnologies

About POP Biotechnologies

POP Biotechnologies leverages its proprietary porphyrin-phospholipid (PoP) nanotechnology to create two primary platform solutions: the SNAP vaccine platform and Chemophototherapy for targeted oncology. The company is advancing a pipeline targeting infectious diseases, cancer, and chronic conditions like Alzheimer's, supported by significant non-dilutive funding from entities like the NIH and CEPI. As a private, platform-focused biotech, POP BIO partners with global health organizations and seeks collaborators to expand the application of its versatile nanoparticle technology.

View full company profile

Therapeutic Areas

Infectious DiseaseOncologyNeurology

Other Oncology (Solid Tumors) Drugs

DrugCompanyPhase
OATD-02MolecurePhase I
ANXVAnnexin PharmaceuticalsPreclinical
Athebody® DARPins for Targeted Radioligands (with POINT Biopharma)AthebioPre-clinical
AB821Asher BiotherapeuticsPreclinical
VEGF KinoidNeovacsPreclinical
Undisclosed Preclinical PipelineOncoResponsePreclinical
Undisclosed Platform ProgramDa Zen TheranosticsPre-clinical
Compound42Abbmira TherapeuticsPre-clinical
Clinical Decision Support ServiceCurematchCommercial
CV6-168CV6 TherapeuticsPhase 1a
HRD Testing SolutionSeqOne GenomicsCommercial
Platform Validation & Partnership DevelopmentSingleCell BiotechnologyPre-clinical